Invasive candidiasis in critical care setting, updated recommendations from "Invasive Fungal Infections-Clinical Forum", Iran.
Invasive candidiasis (IC) bears a high risk of morbidity and mortality in the intensive care units (ICU). With the current advances in critical care and the use of wide-spectrum antibiotics, invasive fungal infections (IFIs) and IC in particular, have turned into a growing concern in the ICU. Further to blood cultures, some auxiliary laboratory tests and biomarkers are developed to enable an earlier detection of infection, however these test are neither consistently available nor validated in our setting. On the other hand, patients' clinical status and local epidemiology data may justify the empiric antifungal approach using the proper antifungal option. The clinical approach to the management of IC in febrile, non-neutropenic critically ill patients has been defined in available international guidelines; nevertheless such recommendations need to be customized when applied to our local practice. Over the past three years, Iranian experts from intensive care and infectious diseases disciplines have tried to draw a consensus on the management of IFI with a particular focus on IC in the ICU. The established IFI-clinical forum (IFI-CF), comprising the scientific leaders in the field, has recently come up with and updated recommendation on the same (June 2014). The purpose of this review is to put together literature insights and Iranian experts' opinion at the IFI-CF, to propose an updated practical overview on recommended approaches for the management of IC in the ICU.
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Ashraf
A
Elhoufi
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Arezoo
A
Ahmadi
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Amir Mohammad Hashem
AM
Asnaashari
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Mohammad Ali
MA
Davarpanah
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Behrooz Farzanegan
BF
Bidgoli
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Omid Moradi
OM
Moghaddam
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Mohammad
M
Torabi-Nami
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Saeed
S
Abbasi
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Malak
M
El-Sobky
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Ali
A
Ghaziani
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Mohammad Hossein
MH
Jarrahzadeh
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Reza
R
Shahrami
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Farzad
F
Shirazian
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Farhad
F
Soltani
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Homeira
H
Yazdinejad
Ashraf Elhoufi, Department of Critical Care Medicine, Dubai Hospital, Dubai Health Authority, Dubai 7272, United Arab Emirates.
Farid
F
Zand
IFI-clinical forum; Intensive care unit; Invasive candidiasis; Iran; Recommendations